Pharmacies in Sandefjord

Pharmacies in Sandefjord form a stable but variable industry with 14 registered companies. In recent years, the industry has shown both strong growth and challenges, with an average EBITDA margin of 7% and a workforce of 87 employees in 2026. Key figures show that Sandefjord is an important central hub for pharmacy activity in Vestfold and Telemark, with a concentration of companies in the city center. At the same time, small companies and newly established businesses contribute to the dynamics of the industry.

Economic Trends

• Sales: The industry reached a peak in 2020 with sales of NOK 563.4 million, but fell to NOK 292.3 million in 2023 before a mild increase to NOK 330.3 million in 2025. Growth from 2023 to 2024 was +12.5%.
• Workforce: The workforce experienced a sharp decline from 2021 to 2022 (-24.1%), but has stabilized since with a marginal increase in 2026.
• EBITDA: The margin has remained stable at around 7%, although some companies have negative values (e.g., Kilen Apotek As and Andebu Apotek As).

Companies in the Industry

• Organizational Structure: 8 of the 14 companies are AS entities, with a total of 88 employees and combined operating income of NOK 204.8 million.
• Key Companies:
• Apotek 1 Nordstjernen (Torggata 1, Sandefjord): 18 employees, operating income NOK 39.3 million.
• Vitusapotek Stokke (Kornmagasingata 7, Stokke): 12 employees, operating income NOK 47.6 million.
• Sandefjord Apotek As (Haslebakken 4, Sandefjord): New company with 0 employees and 0 sales.
• Diverse Conditions: 4 companies have 0 employees (e.g., Digresjon Holding As and Åsane Apotek As), which may indicate inactivity or recent establishment.

Geographic Distribution

• Sandefjord: 7 companies, 76 employees, operating income NOK 157.2 million, sales NOK 154.7 million.
• Stokke: 1 company, 12 employees, operating income NOK 47.6 million, sales NOK 47.3 million.
• Other Areas: Some companies are registered in Andebu, but operations are concentrated in Sandefjord. This underscores the city's role as the main hub for pharmacy activity in the municipality.

Dynamics and Risk

• Bankruptcies: No bankruptcies have been reported in the Sandefjord pharmacy industry, indicating relative stability.
• Challenges:
• Kilen Apotek As has a negative EBITDA of NOK -2.1 million and a sales decline of -37%.
• Andebu Apotek As has a negative operating result of NOK -298,000 and a sales decline of -6%.
• Stable Companies: Most companies have positive EBITDA and stable growth, especially older companies established in the 1960s.

Outlook for Entrepreneurs

• Strengths:
• Stable market with 14 companies and an average EBITDA margin of 7%.
• High concentration of activity in Sandefjord, which may provide opportunities for collaboration and consolidation.
• Challenges:
• Variable sales development and some companies' negative results.
• Increased bankruptcy risk for companies with low operating results.
• Recommendation: Entrepreneurs should consider establishing themselves in Sandefjord, where there is good infrastructure and an established market. SmartGrunder can help find suitable addresses and assess potential development opportunities.

Pharmacies in Sandefjord are an industry with both opportunities and challenges. With a stable EBITDA margin and concentrated activity in the city center, it can be an attractive market for new companies. At the same time, it is important to be aware of individual companies' financial health and global trends in sales and operating results. SmartGrunder can help entrepreneurs find suitable locations and assess potential development opportunities in the municipality.